0001209191-23-005067.txt : 20230126
0001209191-23-005067.hdr.sgml : 20230126
20230126164059
ACCESSION NUMBER: 0001209191-23-005067
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230124
FILED AS OF DATE: 20230126
DATE AS OF CHANGE: 20230126
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: BERNSTEIN HOWARD PHD MD
CENTRAL INDEX KEY: 0001262409
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39662
FILM NUMBER: 23558336
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: SQZ Biotechnologies Co
CENTRAL INDEX KEY: 0001604477
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 462431115
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 200 ARSENAL YARDS BLVD., STE. 210
CITY: WATERTOWN
STATE: MA
ZIP: 02472
BUSINESS PHONE: 617-898-8824
MAIL ADDRESS:
STREET 1: 200 ARSENAL YARDS BLVD., STE. 210
CITY: WATERTOWN
STATE: MA
ZIP: 02472
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2023-01-24
0
0001604477
SQZ Biotechnologies Co
SQZ
0001262409
BERNSTEIN HOWARD PHD MD
200 ARSENAL YARDS BLVD, SUITE 210
WATERTOWN
MA
02472
1
1
0
0
Interim Chief Executive Office
Stock Option
0.73
2023-01-24
4
A
0
830000
0.00
A
2033-01-24
Common Stock
830000
830000
D
The option vests and becomes exercisable as to 25% of the underlying securities on January 24, 2024 and in 36 substantially equal monthly installments thereafter, subject to limited acceleration upon involuntary termination.
/s/ Lawrence Knopf, Attorney in Fact for Howard Bernstein
2023-01-26